Plasma level of calcitonin gene-related peptide in the diagnosis of episodic migraine with comorbid conditions
Comorbid and co-occurring diseases are risk factors for the progression of episodic migraine to chronic migraine. Biomarkers for migraine could help with diagnosis and treatment selection and monitoring. Aim. To examine the role of the plasma level of calcitonin-gene-related peptide (CGRP) in the...
Main Authors: | O. Ye. Dubenko, A. O. Chernenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2022-12-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/261741/266374 |
Similar Items
-
Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine
by: Pi-Chuan Fan, et al.
Published: (2019-01-01) -
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
by: Saigoh K, et al.
Published: (2023-05-01) -
Association of serum levels of calcitonin gene-related peptide and cytokines during migraine attacks
by: Dawei Han
Published: (2019-01-01) -
Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine
by: Kimberly D. Mackenzie, et al.
Published: (2022-11-01) -
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
by: Bo Hu, et al.
Published: (2022-07-01)